MallInckrodt Plc (MNK):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7285)
◆英語タイトル:MallInckrodt Plc (MNK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7285
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers analgesics and gastrointestinal products and immunotherapy and neonatal respiratory critical care therapies; active pharmaceutical ingredients (APIs) and external manufacturing services. The company sells its products either directly or through distributors to retail pharmacies, institutions and various end users. It has subsidiaries in Prince Edward Island, Ireland, Bermuda, Germany, Australia, Canada, Maryland, Delaware, Massachusetts, the UK, California, Netherlands, Alberta, Switzerland, and Luxembourg. Mallinckrodt is headquartered in Surrey, the UK.

MallInckrodt Plc (MNK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MallInckrodt Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MallInckrodt Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MallInckrodt Plc, Medical Equipment, Deal Details 11
Private Equity 11
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 11
Partnerships 12
Mallinckrodt Enters into Licensing Agreement with NeuroproteXeon 12
Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 13
IBA Molecular Forms Joint Venture with Mallinckrodt 14
Terumo BCT Extends Distribution Agreement With Therakos 15
Terumo BCT Expands Agreement with Mallinckrodt 16
Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 17
Mallinckrodt Enters Into Co-Promotion Agreement With China Resources For Optiray 18
Ziehm Imaging Enters Into Agreement With Mallinckrodt For Vascular Applications 19
Debt Offering 20
Mallinckrodt to Raise up to USD1.2 Billion in Private Placement of Notes 20
Asset Transactions 21
Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 21
IBA Molecular Acquires Nuclear Imaging Business from Mallinckrodt 22
Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 23
MediBeacon Acquires Portfolio Of Optical Diagnostic Agent Development Assets From Mallinckrod 24
Acquisition 25
Mallinckrodt Acquires Stratatech 25
Mallinckrodt Pharma Acquires Therakos from Gores Group 26
Mallinckrodt Acquires Ikaria for up to USD2.3 Billion 28
MallInckrodt Plc – Key Competitors 30
MallInckrodt Plc – Key Employees 31
MallInckrodt Plc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 36
Strategy And Business Planning 36
Oct 16, 2017: Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students 36
Financial Announcements 37
Aug 07, 2018: Mallinckrodt reports second quarter 2018 results and raises guidance for 2018 37
May 08, 2018: Mallinckrodt Reports First Quarter 2018 Results 39
Feb 27, 2018: Mallinckrodt Reports Fourth Quarter and Fiscal 2017 Results, Announces 2018 Guidance and Sets 2018 Strategic Priorities 41
Nov 07, 2017: Mallinckrodt Reports Earnings Results for Third Quarter of Fiscal 2017 43
Aug 08, 2017: Mallinckrodt Reports Earnings Results for Second Quarter of Fiscal 2017 45
May 08, 2017: Mallinckrodt Reports Earnings Results for First Quarter of Fiscal 2017 47
Feb 07, 2017: Mallinckrodt Reports Transition Period Results and Announces 2017 Guidance 49
Corporate Communications 51
Oct 01, 2018: Mallinckrodt responds to CBS’ 60 minutes segment 51
Jun 21, 2018: Mallinckrodt Launches Scientific Advisory Council 52
Apr 04, 2018: Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018 53
Apr 04, 2018: Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors 54
Feb 21, 2018: Mallinckrodt Earns Somerset County Planning Board Land Development Honor 55
Feb 01, 2018: Mallinckrodt Names Mark Casey As General Counsel 56
Other Significant Developments 57
Oct 04, 2017: Mallinckrodt Discusses Pipeline Transformation, Company Outlook at Investor Briefing 57
Jul 11, 2017: Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs 58
Jun 06, 2017: Mallinckrodt Updates Facts Refuting Short-Seller Claims 59
Apr 03, 2017: Mallinckrodt Statement on DEA and USAOs Agreement in Principle 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
MallInckrodt Plc, Medical Equipment, Key Facts, 2017 2
MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MallInckrodt Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MallInckrodt Plc, Deals By Market, 2012 to YTD 2018 9
MallInckrodt Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 11
Mallinckrodt Enters into Licensing Agreement with NeuroproteXeon 12
Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 13
IBA Molecular Forms Joint Venture with Mallinckrodt 14
Terumo BCT Extends Distribution Agreement With Therakos 15
Terumo BCT Expands Agreement with Mallinckrodt 16
Mallinckrodt Pharma And Medtronic Enter Into Clinical Agreement For Intrathecal Therapeutics 17
Mallinckrodt Enters Into Co-Promotion Agreement With China Resources For Optiray 18
Ziehm Imaging Enters Into Agreement With Mallinckrodt For Vascular Applications 19
Mallinckrodt to Raise up to USD1.2 Billion in Private Placement of Notes 20
Baxter International Acquires Two Hemostat and Sealant Products from Mallinckrodt 21
IBA Molecular Acquires Nuclear Imaging Business from Mallinckrodt 22
Guerbet Acquires Contrast Media and Delivery Systems Business from Mallinckrodt for USD270 Million 23
MediBeacon Acquires Portfolio Of Optical Diagnostic Agent Development Assets From Mallinckrod 24
Mallinckrodt Acquires Stratatech 25
Mallinckrodt Pharma Acquires Therakos from Gores Group 26
Mallinckrodt Acquires Ikaria for up to USD2.3 Billion 28
MallInckrodt Plc, Key Competitors 30
MallInckrodt Plc, Key Employees 31
MallInckrodt Plc, Other Locations 32
MallInckrodt Plc, Subsidiaries 32

List of Figures
MallInckrodt Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MallInckrodt Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MallInckrodt Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MallInckrodt Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MallInckrodt Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MallInckrodt Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ MallInckrodt Plc (MNK):医療機器:M&Aディール及び事業提携情報(MallInckrodt Plc (MNK) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆